You are currently viewing Biomarker, Sequencing and Phenotyping of Seasonal Hyperacute Panuveitis (SHAPU)

Biomarker, Sequencing and Phenotyping of Seasonal Hyperacute Panuveitis (SHAPU)

Project Summary

In Nepal, there occurs an enigmatic ocular disease called Seasonal Hyperacute Pan uveitis (SHAPU) which presents as a rare endogenous pediatric endophthalmitis but many atypical features like absence of predisposing factors (trauma or surgery), failure to grow organisms from the blood and intra-ocular fluids, seasonal appearance every odd year, unilateral, presenting with a white pupil in red-eye and association with the appearance of moths in the community. The tragedy is excruciating as it affects mostly children, who have long years of life ahead. Though first reported in Nepal in 1975, the etiology remains challenging as to whether it is infective, allergic, immune-mediated, or toxic. Thereby, in absence of definitive aetiology, there are no specific SHAPU treatment guidelines and patients receive a blanket therapy of antimicrobials and steroids with poor visual outcomes.
As mentioned before, there are a wide plethora of organisms (of viral or bacterial) origin behind eye infections including SHAPU. And, the studies that were conducted in Nepal, until now, did align on the causative agents of SHAPU. Some studies have reported presence of the bacteria, and some have reported the presence of virus. Therefore, we have proposed the use of metagenomic next-generation sequencing that can identify infection of any origin through the approach of sequencing, including any co-infections

Study Duration

Phase I:  1/11/2020 – 27/05/2021
Phase II:  07/2022 – 12/2025

Objectives

The overall objective is to perform the immunological, molecular, and genomic analysis in the ocular/blood samples of SHAPU cases. This shall be subsequently utilized for SHAPU National Diagnostic protocol & Treatment guidelines formulation.

Outcomes

In this study, we have identified bacteria responsible for causing SHAPU through mNGS and confirmed them by qPCR using established primer/probes. Additionally, we are planning for prospective sample collection with further investigation of outbreaks in 2023 and 2025.

Team Members

Principal Investigator(s): Prof. Dr. Rajeev Shrestha

Co-Investigator(s): Mr. Nishan Katuwal, Dr. Angira Shrestha, Dr. Ranju Kharel, Dr. Pratap Karki, Dr. Sagun Narayan Joshi, Dr. Ananda Joshi

Project Coordinator (s): Ms. Aastha Shrestha

Research Assistant(s): Ms. Sony Shrestha, Ms. Sneha Shrestha , Ms. Aarjya Tara Bajracharya

Supported by: The Global Ophthalmology Awards Program (GOAP) and University Grant Commission

Collaborating Partners: B.P. Koirala Lion Center for Ophthalmic Studies, Institute of Medicine, Tribhuvan University, Nepal

Publications

1. Upadhyay MP, Kharel Sitaula R, Manandhar A, Gower EW, Karki P, Gurung H, Maharjan I, Reuben S, Karmacharya BM, Joshi SN. The Risk Factors of Seasonal Hyperacute Panuveitis. Ophthalmic Epidemiol. 2021 Jun;28(3):250-257. doi: 10.1080/09286586.2020.1820533. Epub 2020 Sep 27. PMID: 32981405.

https://www.tandfonline.com/doi/full/10.1080/09286586.2020.1820533

2. Kharel RS, Shrestha R, Karki P, Gurung H, KC AK, Katuwal N, Adhikari N, Bhatta R, Shrestha E, Maharjan I, Joshi P, Karmacharya BM, Shrestha A, Sharma AK, Joshi SN, .Upadhyaya MP. Advanced diagnostic approaches for SHAPU: Metagenomic sequencing and interleukin analysis. AJO International. 2024. 1: 100056.

https://www.sciencedirect.com/science/article/pii/S295025352400056X